Teladoc Health Upgraded to Buy with $11 Target on BetterHelp Turnaround
Deutsche Bank upgraded Teladoc Health to Buy with an $11 price target, citing 2% growth in its Q3 Integrated Care segment and a clearer turnaround path for its $236.9M BetterHelp unit. The stock trades at $5.30, down 24.3% year to date and 42.1% over the past year.
1. Deutsche Bank Upgrade to Buy
Deutsche Bank moved Teladoc Health from Hold to Buy, setting an $11 price target—more than double its current share price. The firm highlighted a compelling valuation at current levels and a clear strategic path to stabilize and eventually divest or restructure the $236.9 million BetterHelp mental health segment as key catalysts.
2. Segment Performance and Stock Metrics
Teladoc’s Integrated Care segment grew 2% in Q3 2025, providing a stable revenue base while management works on the BetterHelp turnaround. BetterHelp revenue fell 8% to $236.9 million in that quarter, contributing to Q3 total revenue of $626.4 million versus a $638.4 million consensus. The stock, trading at $5.30, is down 24.3% year to date and 42.1% over the past 12 months, with full-year 2025 revenue guidance of $2.51 billion to $2.54 billion.